Translational Development Acquisition Corp. (TDACU) Accounts Payables (2023 - 2026)
Translational Development Acquisition's (TDACU) quarterly Accounts Payables came in at $224323.0 in Q1 2026, down 0.51% YoY from $225477.0 in Q1 2025, and up 38.21% on a QoQ basis from $162311.0 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Accounts Payables (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 4 years of Accounts Payables data on file, last reported at $224323.0 in Q1 2026.
- Quarterly Accounts Payables fell 0.51% year-over-year to $224323.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $224323.0 (down 0.51% YoY) and the FY2025 annual result came in at $162311.0, up 902.6% from the prior year.
- Accounts Payables rose to $224323.0 in Q1 2026, from $162311.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $225477.0 in Q1 2025 to a low of $1252.0 in Q4 2023.
- A 4-year average of $137650.7 and a median of $162920.0 in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables soared 1193.05% — and 2026, when it dropped 0.51%.
- Tracing TDACU's Accounts Payables over 4 years: stood at $1252.0 in 2023, then soared by 1193.05% to $16189.0 in 2024, then soared by 902.6% to $162311.0 in 2025, then jumped by 38.21% to $224323.0 in 2026.
- The last three Accounts Payables figures came in at $224323.0 (Q1 2026), $162311.0 (Q4 2025), and $171083.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224,323.00 |
| Dec 31, 2025 | 162,311.00 |
| Sep 30, 2025 | 171,083.00 |
| Jun 30, 2025 | 162,920.00 |
| Mar 31, 2025 | 225,477.00 |
| Dec 31, 2024 | 16,189.00 |
| Dec 31, 2023 | 1,252.00 |